Microbiome-Linked Crosstalk in the Gastrointestinal Exposome towards Host Health and Disease

被引:15
|
作者
Moon, Yuseok [1 ,2 ,3 ,4 ]
机构
[1] Pusan Natl Univ, Dept Biomed Sci, Lab Mucosal Exposome & Biomodulat, Sch Med, Yangsan, South Korea
[2] Pusan Natl Univ, Res Inst Basic Sci, Busan, South Korea
[3] Pusan Natl Univ, Med Res Inst, Busan, South Korea
[4] Immunoregulatory Therapeut Grp Brain Busan 21 Pro, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
Gastrointestinal exposome; Microbiota; Gastrointestinal immunity and inflammation; Xenobiotic metabolism;
D O I
10.5223/pghn.2016.19.4.221
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The gastrointestinal exposome represents the integration of all xenobiotic components and host-derived endogenous components affecting the host health, disease progression and ultimately clinical outcomes during the lifespan. The human gut microbiome as a dynamic exposome of commensalism continuously interacts with other exogenous exposome as well as host sentineling components including the immune and neuroendocrine circuit. The composition and diversity of the microbiome are established on the basis of the luminal environment (physical, chemical and biological exposome) and host surveillance at each part of the gastrointestinal lining. Whereas the chemical exposome derived from nutrients and other xenobiotics can influence the dynamics of microbiome community (the stability, diversity, or resilience), the microbiomes reciprocally alter the bioavailability and activities of the chemical exposome in the mucosa. In particular, xenobiotic metabolites by the gut microbial enzymes can be either beneficial or detrimental to the host health although xenobiotics can alter the composition and diversity of the gut microbiome. The integration of the mucosal crosstalk in the exposome determines the fate of microbiome community and host response to the etiologic factors of disease. Therefore, the network between microbiome and other mucosal exposome would provide new insights into the clinical intervention against the mucosal or systemic disorders via regulation of the gut-associated immunological, metabolic, or neuroendocrine system.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 38 条
  • [21] Understanding the role of gut microbiome-host metabolic signal disruption in health and disease
    Holmes, Elaine
    Li, Jia V.
    Athanasiou, Thanos
    Ashrafian, Hutan
    Nicholson, Jeremy K.
    TRENDS IN MICROBIOLOGY, 2011, 19 (07) : 349 - 359
  • [22] Exploring human host–microbiome interactions in health and disease—how to not get lost in translation
    Sarah Lebeer
    Irina Spacova
    Genome Biology, 20
  • [23] FECAL MICROBIOTA TRANSPLANTATION IMPROVES GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE AND RESTORES THE MICROBIOME: A PEDIATRIC EXPERIENCE
    Wong, Wing Fei
    Budree, Shrish
    Osman, Majdi
    Panchal, Pratik
    Kassam, Zain
    Corkins, Mark R.
    Allison, Kim J.
    Dallas, Ronald
    Triplett, Brandon
    Maron, Gabriela M.
    GASTROENTEROLOGY, 2018, 154 (06) : S1046 - S1047
  • [25] Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft-versus-host disease: An exploratory analysis
    Turner, Gavin
    Smith, Madeline
    Hoeschen, Andrea L.
    Wilson, Jessica A.
    Kennedy, Jessica
    Abramson, Max
    Cao, Qing
    El Jurdi, Najla
    MacMillan, Margaret L.
    Weisdorf, Daniel J.
    Blazar, Bruce R.
    Khoruts, Alexander
    Shields-Cutler, Robin R.
    Knights, Dan
    Holtan, Shernan G.
    Rashidi, Armin
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (03) : E69 - E73
  • [26] Gut Microbes Meet Machine Learning: The Next Step towards Advancing Our Understanding of the Gut Microbiome in Health and Disease
    Giuffre, Mauro
    Moretti, Rita
    Tiribelli, Claudio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [27] Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
    Khuat, Lam T.
    Le, Catherine T.
    Pai, Chien-Chun
    Shields-Cutler, Robin
    Holtan, Shernan
    Rashidi, Armin
    Parker, Sarah
    Knights, Dan
    Luna, Jesus I.
    Dunai, Cordelia
    Wang, Ziming
    Sturgill, Ian R.
    Stoffel, Kevin
    Merleev, Alexander A.
    Maverakis, Emanual
    Raybould, Helen
    Chen, Mingyi
    Canter, Robert J.
    Monjazeb, Arta M.
    Ferrara, James L. M.
    Levine, John E.
    Longo, Dan L.
    Abedi, Mehrdad
    Blazar, Bruce R.
    Murphy, William J.
    BLOOD, 2019, 134
  • [28] Butyrate?s role in human health and the current progress towards its clinical application to treat gastrointestinal disease
    Hodgkinson, Kendra
    El Abbar, Faiha
    Dobranowski, Peter
    Manoogian, Juliana
    Butcher, James
    Figeys, Daniel
    Mack, David
    Stintzi, Alain
    CLINICAL NUTRITION, 2023, 42 (02) : 61 - 75
  • [29] Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease
    Cardona, Diana M.
    Detweiler, Claire J.
    Shealy, Michael J.
    Sung, Anthony D.
    Wild, Daniel M.
    Poleski, Martin H.
    Balmadrid, Bryan L.
    Cirrincione, Constance T.
    Howell, David N.
    Sullivan, Keith M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (09) : 1098 - 1105
  • [30] Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk
    Francavilla, Antonio
    Ferrero, Giulio
    Pardini, Barbara
    Tarallo, Sonia
    Zanatto, Laura
    Caviglia, Gian Paolo
    Sieri, Sabina
    Grioni, Sara
    Francescato, Giulia
    Stalla, Francesco
    Guiotto, Cristina
    Crocella, Lucia
    Astegiano, Marco
    Bruno, Mauro
    Calvo, Pier Luigi
    Vineis, Paolo
    Ribaldone, Davide Giuseppe
    Naccarati, Alessio
    GUT MICROBES, 2023, 15 (01)